Health Condition 1: null- Generalized Anxiety Disorder (GAD)as per DSM V criteria
Conditions
Interventions
Intervention1: ALERT Capsules: It contains Celastrus paniculatus (Jyotishmati) Seed oil, and Cow Ghee, processed with Acorus calamus (Vaj) Rhizome, Convolvulus pluricaulis (Shankhapushpi) Whole plant,
Sponsors
Vasu Research Centre VRC A Division of VASU Health Care Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients (Male & Female) between the age group of 18 and 60 years and willing to give consent to participate in the study. (2) Patients having Generalized Anxiety Disorder 7 (GAD-7) score >= 10 (3) Patients having Hamilton Anxiety Rating Score (HAM-A) >= 11 (4) Patients suffering from psycho- physiological insomnia especially due to anxiety.
Exclusion criteria
Exclusion criteria: (1) Patients below 18 years and above 60 years (2) Patients with Hamilton Depression Rating Scale score >13 (3) Patients suffering from any serious liver, kidney and cardiac diseases. (4) Patients having history of any genetic disorders (5) Patients on hypnotic medicine or other drugs which known to cause drowsiness. (6) Lactating & pregnant women (7) Patients on any Psychotropic or Nuerotrophic drugs 4 weeks prior to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes will be effect of drug on subjective and objective parametersTimepoint: baseline, 15th, 30th, 45th & 60th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of drug safety and patientâ??s complianceTimepoint: base line, 15th day, 30th day, 45th day, 60th day | — |
Countries
India
Contacts
Public ContactDr Basavaraj R Tubaki
KLEU BMK Ayurveda Mahavidyalaya
Outcome results
None listed